Liya Wang

603 total citations
39 papers, 430 citations indexed

About

Liya Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Liya Wang has authored 39 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Liya Wang's work include Lung Cancer Treatments and Mutations (5 papers), Head and Neck Cancer Studies (5 papers) and Urticaria and Related Conditions (4 papers). Liya Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Head and Neck Cancer Studies (5 papers) and Urticaria and Related Conditions (4 papers). Liya Wang collaborates with scholars based in United States, China and United Kingdom. Liya Wang's co-authors include He Gong, Dong Zhu, Hui Mao, Qian Yu, Charles A. Staley, David A. Kooby, Lily Yang, Hongyu Zhou, Małgorzata Lipowska and Y. Andrew Wang and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Diabetes.

In The Last Decade

Liya Wang

35 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liya Wang United States 11 125 108 86 85 74 39 430
Guoqiang Liu United States 15 98 0.8× 265 2.5× 112 1.3× 228 2.7× 58 0.8× 29 915
Jianfeng Zheng China 10 59 0.5× 57 0.5× 34 0.4× 92 1.1× 83 1.1× 37 402
David N. Paglia United States 17 112 0.9× 160 1.5× 72 0.8× 164 1.9× 35 0.5× 31 557
Seong Yeong An South Korea 15 92 0.7× 56 0.5× 58 0.7× 53 0.6× 78 1.1× 23 492
Xiuli Zhang China 13 96 0.8× 131 1.2× 26 0.3× 95 1.1× 49 0.7× 49 497
Anand Dusad United States 14 83 0.7× 163 1.5× 27 0.3× 149 1.8× 78 1.1× 21 674
Qingyun Xie China 13 133 1.1× 123 1.1× 62 0.7× 174 2.0× 54 0.7× 38 529
Zuoguan Chen China 11 111 0.9× 71 0.7× 20 0.2× 90 1.1× 88 1.2× 40 443
Yuka Matsuura Japan 12 92 0.7× 153 1.4× 31 0.4× 143 1.7× 64 0.9× 32 484

Countries citing papers authored by Liya Wang

Since Specialization
Citations

This map shows the geographic impact of Liya Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Wang more than expected).

Fields of papers citing papers by Liya Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liya Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Wang. The network helps show where Liya Wang may publish in the future.

Co-authorship network of co-authors of Liya Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liya Wang. A scholar is included among the top collaborators of Liya Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liya Wang. Liya Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Liya, et al.. (2025). ALDH2 Attenuates Blood-Brain Barrier Injury Induced by Cerebral Ischemia/Reperfusion via Alleviating ROS/NLRP3 Inflammasome Axis. Neurochemical Research. 50(4). 224–224. 2 indexed citations
2.
Black, Christopher M., Gleicy M. Hair, Lei Ai, et al.. (2024). Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma. Frontiers in Oncology. 14. 1348045–1348045. 4 indexed citations
3.
Wang, Liya, Adriana Valderrama, Bal Nepal, et al.. (2024). Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USA. Future Oncology. 20(34). 2625–2636.
4.
Black, Christopher M., Glenn J. Hanna, Liya Wang, et al.. (2023). Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma. Frontiers in Oncology. 13. 1160144–1160144. 9 indexed citations
5.
Black, Christopher M., Eric Nadler, John Murphy, et al.. (2023). Real-world study of patients with locally advanced HNSCC in the community oncology setting. Frontiers in Oncology. 13. 1155893–1155893. 3 indexed citations
6.
Xue, Ting, et al.. (2022). Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer. Investigational New Drugs. 40(3). 546–555. 10 indexed citations
7.
8.
Grabner, Michael, Liya Wang, Katherine B. Winfree, et al.. (2021). Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR Cancer. 7(2). e23161–e23161. 2 indexed citations
10.
Hess, Lisa M., Michael Grabner, Liya Wang, et al.. (2020). <p>Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States</p>. PubMed. Volume 11. 27–43. 1 indexed citations
11.
Liao, Ruoxi, Liya Wang, Jiameng Li, et al.. (2019). Hemodialysis access type is associated with blood pressure variability and echocardiographic changes in end-stage renal disease patients. Journal of Nephrology. 32(4). 627–634. 3 indexed citations
12.
13.
Hess, Lisa M., David M. Kern, Gebra Cuyún Carter, et al.. (2017). Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol. JMIR Research Protocols. 6(10). e195–e195. 4 indexed citations
14.
King, Tricia Z., et al.. (2016). Cerebellar Atrophy in Adult Survivors of Childhood Cerebellar Tumor. Journal of the International Neuropsychological Society. 22(5). 501–511. 17 indexed citations
15.
Wang, Liya, et al.. (2015). A numerical study of fluid-structure coupled effect of abdominal aortic aneurysm. Bio-Medical Materials and Engineering. 26(1_suppl). S245–55. 3 indexed citations
16.
Zhou, Hongyu, Weiping Qian, Fatih M. Uckun, et al.. (2015). IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. ACS Nano. 9(8). 7976–7991. 123 indexed citations
17.
Zhang, Qinghe, et al.. (2012). Spatial Database Structure Design of Regional Geology Annals of China. Geo-information Science. 13(6). 720–726.
18.
Wang, Liya, Hongming Du, Wei Tang, et al.. (2011). The application of digital surgical diagnosis and treatment technology: A promising strategy for surgical reconstruction of craniomaxillofacial defect and deformity. Medical Hypotheses. 77(6). 1004–1005. 6 indexed citations
19.
Wei, Lixia, Shunyi Li, Jianhua Yang, et al.. (2010). Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer. Molecular Imaging and Biology. 13(3). 416–423. 25 indexed citations
20.
Wang, Liya, et al.. (2010). Establishment and verification of a non-linear finite element model for human L4&#x2013;L5 lumbar segment. 2010 3rd International Conference on Biomedical Engineering and Informatics. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026